Nettie Buitelaar has been active in the biotech industry for almost 40 years.
She is currently the Chief Business Developer of Biosana Pharma B.V., focused on revolutionizing the biological drug market through two breakthrough technologies: the oral formulation of mAbs and the disruptive biological drug manufacturing process.
Prior to 2015, she was the MD of Leiden Bio Science Park for 9 years, overseeing over 100 companies active in Life Sciences with a turnover exceeding € 5B.
She is an active Board member of several Life Science companies and member of various advisory and steering committees for the European region and Biotech industry foundations in the Netherlands.
Previously, she was the MD of Competence Center Life Sciences, a network organisation to develop the life sciences cluster in the Province of South-Holland; a Business Manager for Xendo, a biopharmaceutical services company; MD of BioPartner Network, an initiative established by the Dutch Ministry of Economic Affairs to stimulate entrepreneurship in the life sciences in The Netherlands; Senior business research analyst at Gilde Investment Management; Head of the Department of Institute for Agrotechnological Research; and Project manager at TNO Food and Nutrition.
Nettie holds a PhD in BioProcess Engineering, with undergraduate studies in Food Technology from University of Wageningen
And an MBA from TSM Business School